IL-27 AND THE REGULATION OF INNATE AND ADAPTIVE IMMUNITY DURING TOXOPLASMOSIS
Degree type
Graduate group
Discipline
Subject
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Contributor
Abstract
The cytokine IL-27 is a potent negative regulator of the inflammatory response to the pathogen Toxoplasma gondii, and the majority of the studies on IL-27 during this infection have focused on its ability to limit T cell responses. The basis for this suppressive activity is unclear, but it was proposed that the ability of IL-27 to promote T cell expression of inhibitory receptors (such as TIGIT and PD-L1) contributed to this activity. In chapter 2, the role of TIGIT during infection was assessed and indicated it was not a critical mediator of the suppressive effects of IL-27. In chapter 3, the impact of IL-27 neutralization on acute and chronic infection was examined and these data sets highlighted that in the absence of IL-27 there were enhanced monocyte responses, a cell type that does not express the IL-27R. During the later phase of infection, the overactive CD4+ T cell responses observed in the absence of IL-27 contributed to the increased monocyte response. However, analysis in chapter 4 of the most proximal events during infection-induced emergency myelopoiesis revealed that haemopoietic stem cells in the bone marrow express high levels of the IL-27R and that during infection IL-27 is a negative regulator of their differentiation into monocytes. Additionally, these studies revealed that IL-27 protected these stem cells from infection induced exhaustion. Thus, these studies highlight that IL-27 acts at multiple points during infection to limit key innate and adaptive events that contribute to infection-induced pathology.